Advertisement
News
Advertisement

Pharmasset to Present at Canaccord Genuity Growth Conference

Sun, 08/07/2011 - 10:40pm
Bio-Medicine.Org

PRINCETON, N.J., Aug. 7, 2011 /PRNewswire/ --- Pharmasset, Inc. (Nasdaq: VRUS) announces that management will present at the Canaccord Genuity Growth Conference to be held August 10 to 11, 2011 at the Intercontinental Hotel, Boston, Massachusetts. Schaefer Price, Pharmasset's President and Chief Executive Officer, will provide an overview of the company at the Canaccord Genuity conference on Thursday, August 11, 2011 at 9:30 AM (ET).

To access a simultaneous webcast of Mr. Price's overview via the internet, log on to the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm. Please connect to the website at least ten minutes prior to the start of the presentation to ensure adequate time for a reliable connection and any software download that may be necessary for the webcast.

A replay of the webcasts will be available on Pharmasset's website for thirty days following the conference. The investor presentation will be available for download in PDF format immediately following the presentation in the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm.

About Pharmasset

Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. Our research and development efforts are focused on nucleoside/tide analogs, a class of compounds which act as alternative substrates for the viral polymerase, thus inhibiting viral replication. We currently have three clinical-stage product candidates adv

'/>"/>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading